Financial & Policy Research Insights

This research explores how potential PBM reform, IRA implementation, and pricing policy shifts may provide moderate tailwinds for retail pharmacy chains like CVS, WBA, and RiteAid in 2025.

Washington Analysis Healthcare Team hosted a conference call with a leading UK-based strategic advisor to understand better the potential...

An exclusive policy event in Washington, D.C., covering key legislative developments in healthcare, consumer goods, Medicaid, Medicare, and RFK Jr.'s Make America Healthy Again priorities.

2025 will bring major healthcare policy shifts, impacting ACA subsidies, Medicare payments, drug pricing, and REITs.

Republicans will have a unified government (White House, House, and Senate) heading into 2025.

With less than 60 days until November 5, can meaningful change still happen, or are we headed for more of the same or worse?

The performance of the S&P 500 in the first half of the year was particularly robust.

CFRA webinar Artificial Intelligence – Expectations Looking Ahead for The Technology Sector.

Looking ahead to 2024, CFRA banking analysts will examine the Federal Reserve's pivot from...

The relationship between market performance and policy is significant.